LiveActive security incident?Get immediate response
CVE Record

CVE-2014-5401: Hospira MedNet Code Injection

Hospira MedNet software version 5.8 and prior uses vulnerable versions of the JBoss Enterprise Application Platform software that may allow unauthenticated users to execute arbitrary code on the target system. Hospira has developed a new version of the MedNet software, MedNet 6.1. Existing versions of MedNet can be upgraded to MedNet 6.1.

CriticalCVSS 10Not KEV-listedUpdated
Glexia's TakeAutomated analysiscritical

Security readout for executives and security teams

Plain-English summary

CVE-2014-5401 is a critical flaw in Hospira MedNet 5.8 and earlier. The software includes vulnerable JBoss Enterprise Application Platform components that may let an unauthenticated network user run arbitrary code on the MedNet system. Hospira’s stated remediation is upgrading to MedNet 6.1.

Executive priority

Make this a high-priority remediation item for healthcare environments using Hospira MedNet. The business risk is potential full system compromise without authentication, but the provided evidence does not confirm active exploitation.

Technical view

The issue is classified as CWE-94 code injection with CVSS v2 score 10.0. The attack vector is network, low complexity, and requires no authentication, with complete confidentiality, integrity, and availability impact according to the supplied CVSS vector.

Likely exposure

Exposure is most likely where Hospira MedNet 5.8 or earlier remains deployed and reachable over a network. The source bundle does not identify specific deployment architectures, internet exposure, or downstream bundled products beyond Hospira MedNet.

Exploitation context

The source bundle does not state active exploitation, and the CVE is not listed as CISA KEV. Treat the vulnerability as urgent because unauthenticated remote code execution against medical infrastructure software has high operational impact, not because exploitation is confirmed here.

Researcher notes

Focus validation on version evidence, network exposure, and whether bundled JBoss EAP components match the vulnerable MedNet releases. Do not assume other Hospira products are affected unless confirmed by vendor or CISA sources.

Mitigation direction

  • Upgrade affected Hospira MedNet deployments to MedNet 6.1.
  • Confirm upgrade planning against Hospira and CISA advisory guidance.
  • Limit network reachability to MedNet systems while remediation is pending.
  • Prioritize systems supporting clinical or medication delivery operations.

Validation and detection

  • Inventory Hospira MedNet installations and record software versions.
  • Identify any MedNet 5.8 or earlier systems still running.
  • Confirm whether MedNet services are reachable from untrusted networks.
  • Verify upgraded systems report MedNet 6.1 after remediation.
  • Document compensating controls for any delayed upgrades.
Prepared
Confidence
high
Sources
4

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · medium confidence lookup

CWE-94: Code execution behavior lookup

Code execution and unsafe deserialization weaknesses often justify reviewing execution behavior and process telemetry. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
description · low confidence lookup

Execution behavior lookup

The CVE wording references code or command execution, so execution technique review may help defensive triage. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2014-5401 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Critical
CVSS
10 (2.0)
Known Exploited
No
Published

Vector: AV:N/AC:L/Au:N/C:C/I:C/A:C

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
4Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
10CVSS 2.0CriticalAV:N/AC:L/Au:N/C:C/I:C/A:C1010Primary CVE score

Vulnerability scoring details

Base CVSS 2.0 score

10Critical
CVSS 2.0 vector shape for CVE-2014-5401Access VectorAccess ComplexityAuthenticationConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: AV:N/AC:L/Au:N/C:C/I:C/A:C

Access Vector
NetworkAdjacentLocal
Access Complexity
LowMediumHigh
Authentication
NoneSingleMultiple
Confidentiality Impact
CompletePartialNone
Integrity Impact
CompletePartialNone
Availability Impact
CompletePartialNone
Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
HospiraMedNet0, 6.1unaffected
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-94 · source CWE mapping

Improper Control of Generation of Code ('Code Injection')

Improper Control of Generation of Code ('Code Injection') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.